Clinical Research Directory
Browse clinical research sites, groups, and studies.
Anifrolumab Real-world Treatment Outcomes in Systemic Lupus Erythematosus
Sponsor: AstraZeneca
Summary
The Polish multicentre observational (non-interventional) study aiming to collect data on the characteristic of patients with systemic lupus erythematosus and clinical outcomes of anifrolumab administered in the scope of routine clinical practice.
Official title: Anifrolumab Real-world Treatment Outcomes in Polish Patients With Systemic Lupus Erythematosus (SLE). Multicenter, Non-interventional Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2025-02-28
Completion Date
2028-06-30
Last Updated
2026-03-12
Healthy Volunteers
No
Conditions
Interventions
Anifrolumab
Anifrolumab 300 mg concentrate for solution for infusion
Locations (11)
Research Site
Bydgoszcz, Poland
Research Site
Bytom, Poland
Research Site
Gdansk, Poland
Research Site
Katowice, Poland
Research Site
Krakow, Poland
Research Site
Lodz, Poland
Research Site
Lublin, Poland
Research Site
Poznan, Poland
Research Site
Rzeszów, Poland
Research Site
Warsaw, Poland
Research Site
Wroclaw, Poland